Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
All voices matter
CARsgen Therapeutics
First international patient treated with China’s solid tumor CAR-T therapy
Jiahui International Cancer Center in Shanghai announced on July 6 that it has begun treating the world's first international patient with Satri-cel, the recently approved CAR-T cell therapy for solid tumors. The milestone comes just two weeks after China's National…
China approves world’s first CAR-T therapy for solid tumors
China's National Medical Products Administration on Monday approved CARsgen Therapeutics' satricabtagene autoleucel, marking the first regulatory approval anywhere in the world for a CAR-T cell therapy targeting solid tumors. The treatment, also known as satri-cel, is indicated for patients with…